Measuring prognostic markers in breast cancer cells opens up possibilities for broad applications of this technology to tissue samples obtained from needle or surgical biopsies of patients with suspected breast cancers. Furthermore, it's possible this approach may also be applied to a broad range of other solid tumors, including colon, ovarian, prostate and gastric cancer, to name a few.